Pharmacology Quiz: Diuretics For Hypertension
20 questions · exam conditions
0:00
Diuretics For HypertensionQuestion 1 of 20

A patient with hypertension also has severe peripheral edema due to systolic heart failure. While a thiazide diuretic may contribute to blood pressure control, a loop diuretic is generally required. What is the principal reason for preferring a loop diuretic in this setting?

Loop diuretics possess a significantly higher capacity for solute and water excretion.
Thiazide diuretics have a paradoxical antidiuretic effect in patients with severe heart failure.
Loop diuretics cause less potassium and magnesium wasting, which is safer in heart failure.
Thiazide diuretics lose all efficacy in the presence of activated RAAS, common in heart failure.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Diuretics For Hypertension

Practice Diuretics For Hypertension in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Diuretics For Hypertension, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with hypertension also has severe peripheral edema due to systolic heart failure. While a thiazide diuretic may contribute to blood pressure control, a loop diuretic is generally required. What is the principal reason for preferring a loop diuretic in this setting?

  1. Loop diuretics possess a significantly higher capacity for solute and water excretion. (correct answer)
  2. Thiazide diuretics have a paradoxical antidiuretic effect in patients with severe heart failure.
  3. Loop diuretics cause less potassium and magnesium wasting, which is safer in heart failure.
  4. Thiazide diuretics lose all efficacy in the presence of activated RAAS, common in heart failure.
Explanation: When you encounter a patient with both hypertension and heart failure with severe edema, you need to understand the fundamental differences in diuretic potency and clinical applications. Loop diuretics like furosemide work at the thick ascending limb of the loop of Henle, blocking the Na-K-2Cl cotransporter. This mechanism allows them to excrete up to 20-25% of filtered sodium, making them the most potent diuretics available. In contrast, thiazide diuretics work at the distal convoluted tubule and can only excrete about 5-10% of filtered sodium. When a patient has severe peripheral edema from systolic heart failure, you need maximum fluid removal capacity - this is why option A is correct. Option B is incorrect because thiazide diuretics don't have paradoxical antidiuretic effects in heart failure patients. Option C reverses the truth - loop diuretics actually cause more electrolyte wasting than thiazides, particularly potassium and magnesium, which is why careful monitoring is essential. Option D overstates the case; while RAAS activation in heart failure can reduce thiazide effectiveness, they don't lose "all efficacy." The key principle here is matching diuretic potency to clinical need. Mild hypertension might respond to thiazides, but severe volume overload requires the superior natriuretic capacity of loop diuretics. Study tip: Remember the "power hierarchy" of diuretics: loop > thiazide > potassium-sparing. For boards, when you see severe edema or heart failure, think loop diuretics first for their unmatched ability to mobilize large volumes of fluid.

Question 2

A patient on chronic high-dose furosemide therapy exhibits a progressively diminishing response, a phenomenon known as diuretic braking or resistance. Which compensatory physiological change in the nephron is the primary driver of this effect?

  1. Structural downregulation and decreased expression of the Na-K-2Cl cotransporter in the thick ascending limb.
  2. Hypertrophy of distal convoluted tubule cells with increased expression of the Na-Cl cotransporter. (correct answer)
  3. Decreased secretion of aldosterone from the adrenal cortex due to negative feedback from volume depletion.
  4. Reduced blood flow to the proximal tubule, leading to decreased filtration and solute delivery.
Explanation: Chronic blockade of sodium reabsorption in the loop of Henle by furosemide leads to an increased delivery of sodium to the distal nephron. This chronic increase in solute load stimulates a compensatory hypertrophy and hyperplasia of cells in the distal convoluted tubule (DCT). These hypertrophied cells exhibit increased numbers of Na-Cl cotransporters (NCC), leading to enhanced sodium reabsorption at this site, which partially counteracts the effect of the loop diuretic upstream.

Question 3

A patient on chronic high-dose furosemide therapy exhibits a progressively diminishing response, a phenomenon known as diuretic braking or resistance. Which compensatory physiological change in the nephron is the primary driver of this effect?

  1. Structural downregulation and decreased expression of the Na-K-2Cl cotransporter in the thick ascending limb.
  2. Hypertrophy of distal convoluted tubule cells with increased expression of the Na-Cl cotransporter. (correct answer)
  3. Decreased secretion of aldosterone from the adrenal cortex due to negative feedback from volume depletion.
  4. Reduced blood flow to the proximal tubule, leading to decreased filtration and solute delivery.
Explanation: Chronic blockade of sodium reabsorption in the loop of Henle by furosemide leads to an increased delivery of sodium to the distal nephron. This chronic increase in solute load stimulates a compensatory hypertrophy and hyperplasia of cells in the distal convoluted tubule (DCT). These hypertrophied cells exhibit increased numbers of Na-Cl cotransporters (NCC), leading to enhanced sodium reabsorption at this site, which partially counteracts the effect of the loop diuretic upstream.

Question 4

A patient being treated with high-dose furosemide for hypertension associated with heart failure presents with profound muscle weakness and constipation. An ECG reveals prominent U waves. These findings are most directly caused by the diuretic's effect on which transporter and resulting electrolyte abnormality?

  1. Inhibition of the Na-Cl symporter leading to hypomagnesemia.
  2. Inhibition of the Na-K-2Cl cotransporter leading to hypokalemia. (correct answer)
  3. Inhibition of the epithelial sodium channel leading to hyperkalemia.
  4. Inhibition of the Na-K-2Cl cotransporter leading to hypercalcemia.
Explanation: Furosemide is a loop diuretic that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle. This action leads to significant potassium wasting and subsequent hypokalemia. The clinical manifestations of severe hypokalemia include muscle weakness, constipation (due to smooth muscle dysfunction), and characteristic ECG changes such as prominent U waves, T wave flattening, and ST depression.

Question 5

A 68-year-old woman with a history of osteoporosis and newly diagnosed essential hypertension requires pharmacotherapy. Her physician considers initiating a diuretic. Which of the following agents would be most appropriate for this patient, considering both of her medical conditions?

  1. Furosemide, as it directly stimulates osteoblast activity through enhanced calcium mobilization.
  2. Hydrochlorothiazide, as it enhances calcium-sensing receptor activity in parathyroid glands.
  3. Furosemide, as its potent diuretic effect helps concentrate calcium within bone matrix.
  4. Hydrochlorothiazide, as it increases calcium reabsorption in the distal convoluted tubule, reducing urinary calcium losses. (correct answer)
Explanation: Thiazide diuretics, such as hydrochlorothiazide, inhibit the Na-Cl cotransporter in the distal convoluted tubule (DCT). This leads to a lower intracellular Na+ concentration, which enhances the activity of the basolateral Na+/Ca2+ exchanger, thereby increasing passive Ca2+ reabsorption through apical channels. The net effect is decreased renal calcium excretion (hypocalciuria), which can be beneficial for patients with osteoporosis. Furosemide (a loop diuretic) has the opposite effect; it increases calcium excretion and is not ideal for this patient.

Question 6

A clinician argues that furosemide should be superior to hydrochlorothiazide for essential hypertension due to its much higher diuretic ceiling. Why is this reasoning flawed for the long-term management of uncomplicated hypertension?

  1. The maximal antihypertensive effect of thiazides is significantly greater than that of loop diuretics.
  2. Furosemide's antihypertensive effect is primarily due to venodilation, which is not sustained with chronic oral therapy.
  3. The antihypertensive dose-response curve for thiazides is much steeper than for loop diuretics.
  4. The short, intense diuresis from furosemide leads to stronger counter-regulatory responses and less stable 24-hour BP control. (correct answer)
Explanation: While loop diuretics are more potent diuretics (higher ceiling), this doesn't translate to better chronic antihypertensive efficacy. The rapid and profound diuresis caused by short-acting agents like furosemide leads to abrupt volume changes, which triggers a more robust activation of compensatory systems (e.g., RAAS, sympathetic nervous system). This, combined with its short half-life, results in periods of sodium retention between doses and less consistent blood pressure control compared to the milder, longer-acting profile of thiazides.

Question 7

A 55-year-old patient stabilized on chlorthalidone for hypertension begins taking ibuprofen 600 mg three times daily for osteoarthritis. Over the next two weeks, her home blood pressure readings are consistently elevated. Which mechanism best explains this drug interaction?

  1. Ibuprofen competitively inhibits the tubular secretion of chlorthalidone, reducing its concentration at the distal tubule.
  2. Ibuprofen induces the CYP450 enzymes responsible for the metabolic clearance of chlorthalidone.
  3. Ibuprofen inhibits renal prostaglandin synthesis, leading to afferent arteriole vasoconstriction and reduced renal blood flow. (correct answer)
  4. Ibuprofen displaces chlorthalidone from albumin, increasing its volume of distribution and lowering plasma concentration.
Explanation: NSAIDs, like ibuprofen, inhibit cyclooxygenase (COX) enzymes, which reduces the synthesis of renal prostaglandins (e.g., PGE2, PGI2). These prostaglandins are crucial for maintaining renal blood flow and glomerular filtration rate, particularly in the context of diuretic-induced volume contraction. By inhibiting these vasodilatory prostaglandins, NSAIDs cause afferent arteriole vasoconstriction, reduce renal blood flow, and blunt the natriuretic and antihypertensive effects of diuretics.

Question 8

For the initial management of a patient with uncomplicated primary hypertension, a thiazide diuretic like hydrochlorothiazide is often preferred over a loop diuretic like furosemide. What is the primary pharmacokinetic and pharmacodynamic rationale for this choice?

  1. Thiazides have a higher diuretic ceiling, allowing for greater blood pressure reduction at maximal doses.
  2. Furosemide undergoes extensive first-pass metabolism, leading to unreliable antihypertensive effects.
  3. Thiazides have a longer duration of action, which provides more consistent 24-hour blood pressure control. (correct answer)
  4. Furosemide causes a lower incidence of metabolic disturbances such as hyperglycemia and hyperlipidemia.
Explanation: Thiazide diuretics have a longer half-life and duration of action (e.g., HCTZ: 12-18 hours; chlorthalidone: 24-72 hours) compared to loop diuretics (e.g., furosemide: 4-6 hours). This longer duration provides smoother, more sustained blood pressure control throughout the day with once-daily dosing. The potent, short-acting diuresis from furosemide can lead to more significant volume depletion and stronger activation of compensatory mechanisms (like RAAS), making it less ideal for chronic, stable hypertension management.

Question 9

A patient on hydrochlorothiazide 25 mg daily has the following serum lab results:

Na⁺: 138 mEq/L K⁺: 3.2 mEq/L Cl⁻: 91 mEq/L HCO₃⁻: 32 mEq/L Ca²⁺: 10.9 mg/dL

Based on the laboratory data provided, which of the following best describes the patient's acid-base and electrolyte status?

  1. Hypokalemic, hypochloremic metabolic alkalosis with hypercalcemia. (correct answer)
  2. Normokalemic, normochloremic metabolic alkalosis with hypocalcemia.
  3. Hypokalemic, hyperchloremic metabolic acidosis with hypercalcemia.
  4. Hyperkalemic, hypochloremic metabolic acidosis with normocalcemia.
Explanation: When analyzing a patient on thiazide diuretics like hydrochlorothiazide, you should systematically evaluate electrolytes and acid-base status, as these medications have predictable effects on renal handling of ions. Let's interpret each lab value. Potassium at 3.2 mEq/L indicates hypokalemia (normal: 3.5-5.0). Chloride at 91 mEq/L shows hypochloremia (normal: 98-107). Bicarbonate at 32 mEq/L reveals metabolic alkalosis (normal: 22-28). Calcium at 10.9 mg/dL indicates hypercalcemia (normal: 8.5-10.5). This constellation fits perfectly with thiazide effects: they block sodium-chloride reabsorption in the distal tubule, causing sodium and chloride loss, while promoting calcium retention and potassium wasting through compensatory aldosterone activation. Answer A correctly identifies all abnormalities: hypokalemic, hypochloremic metabolic alkalosis with hypercalcemia. This matches the expected thiazide toxidrome. Answer B incorrectly states the patient is normokalemic and normochloremic, missing the clear hypokalemia and hypochloremia. It also incorrectly suggests hypocalcemia when calcium is elevated. Answer C misidentifies the acid-base disorder as metabolic acidosis rather than alkalosis, despite the elevated bicarbonate clearly indicating alkalosis. It also incorrectly states hyperchloremic when chloride is low. Answer D incorrectly suggests hyperkalemia (opposite of what thiazides cause), metabolic acidosis instead of alkalosis, and normocalcemia despite the elevated level. Study tip: Remember "thiazides cause the four Hs": Hypokalemia, Hypochloremia, Hypercalcemia, and High bicarbonate (metabolic alkalosis). This pattern will help you quickly recognize thiazide-related electrolyte disturbances.

Question 10

The thiazide-like diuretic indapamide is thought to have an antihypertensive mechanism that extends beyond its effect on the Na-Cl cotransporter. What additional property contributes to its vasodilatory and blood pressure-lowering effects?

  1. Inhibition of carbonic anhydrase in vascular smooth muscle.
  2. Beta-1 adrenergic receptor antagonism.
  3. Stimulation of nitric oxide release from the endothelium.
  4. Inhibition of calcium influx through voltage-gated calcium channels. (correct answer)
Explanation: In addition to its diuretic action in the kidney, indapamide has been shown to have direct vasodilatory effects. This is attributed, in part, to its ability to inhibit calcium influx through L-type voltage-gated calcium channels in vascular smooth muscle cells. This action reduces intracellular calcium concentration, leading to smooth muscle relaxation, decreased peripheral vascular resistance, and a further reduction in blood pressure, distinguishing it from other thiazides like HCTZ.

Question 11

Chlorthalidone is often preferred over hydrochlorothiazide for hypertension management based on evidence from major clinical trials. This preference is primarily attributed to which pharmacologic property of chlorthalidone?

  1. A more favorable metabolic profile with a lower risk of hyperglycemia and dyslipidemia.
  2. A unique mechanism involving aldosterone receptor antagonism in addition to its diuretic effect.
  3. A significantly longer plasma half-life and duration of action, ensuring more consistent BP control. (correct answer)
  4. The absence of a sulfonamide moiety, which eliminates the risk of hypersensitivity reactions.
Explanation: The primary reason for chlorthalidone's superior performance in some hypertension trials is its pharmacokinetic profile. It has a much longer half-life (40-60 hours) compared to hydrochlorothiazide (8-15 hours). This results in more sustained and consistent 24-hour blood pressure reduction, including better nocturnal blood pressure control, which is thought to contribute to improved cardiovascular outcomes. Both drugs have similar metabolic side effect profiles and are sulfonamide derivatives.

Question 12

A patient with chronic hypertension managed with oral chlorthalidone presents to the emergency department with a blood pressure of 220/115 mmHg, respiratory distress, and bibasilar crackles on lung auscultation. In addition to intravenous antihypertensives, which modification to diuretic therapy is most appropriate?

  1. Administer a double dose of oral chlorthalidone immediately.
  2. Switch to an equivalent oral dose of torsemide for better bioavailability.
  3. Administer intravenous furosemide. (correct answer)
  4. Add oral spironolactone to counteract aldosterone escape.
Explanation: This patient is in a hypertensive emergency with signs of acute decompensated heart failure (pulmonary edema). This situation requires rapid and potent diuresis to reduce preload and relieve pulmonary congestion. Intravenous furosemide is the drug of choice because it has a rapid onset of action (within minutes) and is a potent diuretic capable of removing large fluid volumes. Oral diuretics are too slow-acting and less effective for this acute, life-threatening condition.

Question 13

A 68-year-old woman with a history of osteoporosis and newly diagnosed essential hypertension requires pharmacotherapy. Her physician considers initiating a diuretic. Which of the following agents would be most appropriate for this patient, considering both of her medical conditions?

  1. Furosemide, as it directly stimulates osteoblast activity through enhanced calcium mobilization.
  2. Hydrochlorothiazide, as it enhances calcium-sensing receptor activity in parathyroid glands.
  3. Furosemide, as its potent diuretic effect helps concentrate calcium within bone matrix.
  4. Hydrochlorothiazide, as it increases calcium reabsorption in the distal convoluted tubule, reducing urinary calcium losses. (correct answer)
Explanation: Thiazide diuretics, such as hydrochlorothiazide, inhibit the Na-Cl cotransporter in the distal convoluted tubule (DCT). This leads to a lower intracellular Na+ concentration, which enhances the activity of the basolateral Na+/Ca2+ exchanger, thereby increasing passive Ca2+ reabsorption through apical channels. The net effect is decreased renal calcium excretion (hypocalciuria), which can be beneficial for patients with osteoporosis. Furosemide (a loop diuretic) has the opposite effect; it increases calcium excretion and is not ideal for this patient.

Question 14

A 55-year-old patient stabilized on chlorthalidone for hypertension begins taking ibuprofen 600 mg three times daily for osteoarthritis. Over the next two weeks, her home blood pressure readings are consistently elevated. Which mechanism best explains this drug interaction?

  1. Ibuprofen competitively inhibits the tubular secretion of chlorthalidone, reducing its concentration at the distal tubule.
  2. Ibuprofen induces the CYP450 enzymes responsible for the metabolic clearance of chlorthalidone.
  3. Ibuprofen inhibits renal prostaglandin synthesis, leading to afferent arteriole vasoconstriction and reduced renal blood flow. (correct answer)
  4. Ibuprofen displaces chlorthalidone from albumin, increasing its volume of distribution and lowering plasma concentration.
Explanation: NSAIDs, like ibuprofen, inhibit cyclooxygenase (COX) enzymes, which reduces the synthesis of renal prostaglandins (e.g., PGE2, PGI2). These prostaglandins are crucial for maintaining renal blood flow and glomerular filtration rate, particularly in the context of diuretic-induced volume contraction. By inhibiting these vasodilatory prostaglandins, NSAIDs cause afferent arteriole vasoconstriction, reduce renal blood flow, and blunt the natriuretic and antihypertensive effects of diuretics.

Question 15

For the initial management of a patient with uncomplicated primary hypertension, a thiazide diuretic like hydrochlorothiazide is often preferred over a loop diuretic like furosemide. What is the primary pharmacokinetic and pharmacodynamic rationale for this choice?

  1. Thiazides have a higher diuretic ceiling, allowing for greater blood pressure reduction at maximal doses.
  2. Furosemide undergoes extensive first-pass metabolism, leading to unreliable antihypertensive effects.
  3. Thiazides have a longer duration of action, which provides more consistent 24-hour blood pressure control. (correct answer)
  4. Furosemide causes a lower incidence of metabolic disturbances such as hyperglycemia and hyperlipidemia.
Explanation: Thiazide diuretics have a longer half-life and duration of action (e.g., HCTZ: 12-18 hours; chlorthalidone: 24-72 hours) compared to loop diuretics (e.g., furosemide: 4-6 hours). This longer duration provides smoother, more sustained blood pressure control throughout the day with once-daily dosing. The potent, short-acting diuresis from furosemide can lead to more significant volume depletion and stronger activation of compensatory mechanisms (like RAAS), making it less ideal for chronic, stable hypertension management.

Question 16

A patient with hypertension requires a diuretic but reports a history of Stevens-Johnson syndrome after taking trimethoprim-sulfamethoxazole. Which statement most accurately reflects the clinical considerations for diuretic selection?

  1. Thiazide diuretics must be avoided, but loop diuretics such as furosemide are a safe alternative as they are not sulfonamides.
  2. All thiazide and loop diuretics are absolutely contraindicated due to a high certainty of life-threatening cross-reactivity.
  3. The reaction was to a sulfa antibiotic, which is mechanistically distinct from diuretic sulfonamides, posing no cross-reactivity risk.
  4. While most loop and thiazide diuretics are sulfonamide derivatives, evidence for cross-reactivity is limited, but a non-sulfonamide option like ethacrynic acid exists. (correct answer)
Explanation: Most thiazide (e.g., HCTZ) and loop diuretics (e.g., furosemide, bumetanide) contain a sulfonamide moiety. However, they are structurally different from sulfonamide antibiotics. While caution is warranted, the risk of cross-reactivity between sulfonamide antibiotics and non-antibiotic sulfonamides is considered very low. For a patient with a severe reaction like SJS, the most prudent approach is to acknowledge the theoretical risk and consider a non-sulfonamide diuretic if possible. Ethacrynic acid is a loop diuretic that lacks a sulfonamide structure and is the classic alternative in this scenario.

Question 17

A patient with hypertension is prescribed combination therapy with lisinopril and hydrochlorothiazide. What is the most significant synergistic advantage of this combination with respect to electrolyte homeostasis?

  1. Lisinopril directly prevents thiazide-induced hyperuricemia by promoting uric acid secretion.
  2. The kaliuretic effect of hydrochlorothiazide is attenuated by the potassium-sparing effect of lisinopril. (correct answer)
  3. Hydrochlorothiazide counteracts the risk of hyponatremia that can be caused by ACE inhibitors.
  4. The combination normalizes serum calcium levels, preventing both hyper- and hypocalcemia.
Explanation: Hydrochlorothiazide increases potassium excretion, leading to a risk of hypokalemia. Lisinopril, an ACE inhibitor, blocks the production of angiotensin II and subsequently aldosterone. Reduced aldosterone levels decrease the activity of sodium channels (ENaC) and potassium channels (ROMK) in the collecting duct, leading to decreased potassium secretion (a potassium-sparing effect). When used together, these opposing effects on potassium handling help to maintain serum potassium within the normal range.

Question 18

Chlorthalidone is often preferred over hydrochlorothiazide for hypertension management based on evidence from major clinical trials. This preference is primarily attributed to which pharmacologic property of chlorthalidone?

  1. A more favorable metabolic profile with a lower risk of hyperglycemia and dyslipidemia.
  2. A unique mechanism involving aldosterone receptor antagonism in addition to its diuretic effect.
  3. A significantly longer plasma half-life and duration of action, ensuring more consistent BP control. (correct answer)
  4. The absence of a sulfonamide moiety, which eliminates the risk of hypersensitivity reactions.
Explanation: The primary reason for chlorthalidone's superior performance in some hypertension trials is its pharmacokinetic profile. It has a much longer half-life (40-60 hours) compared to hydrochlorothiazide (8-15 hours). This results in more sustained and consistent 24-hour blood pressure reduction, including better nocturnal blood pressure control, which is thought to contribute to improved cardiovascular outcomes. Both drugs have similar metabolic side effect profiles and are sulfonamide derivatives.

Question 19

A patient presents with a chronic electrolyte pattern of hypokalemia, metabolic alkalosis, hypomagnesemia, and hypercalcemia. This laboratory profile is most analogous to the chronic pharmacologic effect of which class of antihypertensive agents?

  1. Loop diuretics
  2. Thiazide diuretics (correct answer)
  3. Potassium-sparing diuretics
  4. ACE inhibitors
Explanation: This specific combination of electrolyte disturbances mirrors Gitelman syndrome, a genetic disorder involving a loss-of-function mutation in the Na-Cl cotransporter (NCC). This is the same transporter inhibited by thiazide diuretics. Chronic use of thiazides thus produces a phenocopy of Gitelman syndrome: hypokalemia and metabolic alkalosis (from volume contraction and increased distal Na+ delivery), hypomagnesemia, and characteristic hypercalcemia (due to enhanced Ca2+ reabsorption in the DCT). Loop diuretics would cause hypocalcemia.

Question 20

A patient with chronic hypertension managed with oral chlorthalidone presents to the emergency department with a blood pressure of 220/115 mmHg, respiratory distress, and bibasilar crackles on lung auscultation. In addition to intravenous antihypertensives, which modification to diuretic therapy is most appropriate?

  1. Administer a double dose of oral chlorthalidone immediately.
  2. Switch to an equivalent oral dose of torsemide for better bioavailability.
  3. Administer intravenous furosemide. (correct answer)
  4. Add oral spironolactone to counteract aldosterone escape.
Explanation: This patient is in a hypertensive emergency with signs of acute decompensated heart failure (pulmonary edema). This situation requires rapid and potent diuresis to reduce preload and relieve pulmonary congestion. Intravenous furosemide is the drug of choice because it has a rapid onset of action (within minutes) and is a potent diuretic capable of removing large fluid volumes. Oral diuretics are too slow-acting and less effective for this acute, life-threatening condition.